Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Autophagy and cardiometabolic risk factors
Himanshu Gadgil, PhD, Russell Miller, Jin Kim, Kumar Bala, Yukhti Yachha #DCATWeek2026 #Biopharma #CDMO #Biologics #Biosimilars To view or add a comment, sign in We keep asking NAMs to prove they're "as good as animal studies." But how good are animal studies, really
GLP-1s may not be right for you if any of the following conditions apply: A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
Furthermore, development of small molecule agonists or antagonists is often performed via binding a certain and definite site in the target molecule while PROTAC is not dependent on these certain sites as it is implemented via the efficient building of a ternary complex between the PROTAC molecule, the protein of interest and the E3 ligase
Izzy M, Lee M, Johns-Keating K, Kargoli F, Beckoff S, Chun K, et al
